I have never been a huge fan of CAR-T because of its safety...

I have never been a huge fan of CAR-T because of its safety profile and being an uncontrollable beast.

But omni-car really seems to address this.

SYC explains it in simple terms here:

https://*.com.au/webcast/prescient-therapeutics-investor-briefing-4-november/

Biotechs are rising on the asx, but ptx has not moved. I think with their cash position, ptx100 (which could be worth billions on its own) and omni-car I think a big re-rate is coming. So much realistic potential here.

Short term potential too, with ptx100 updates coming, omni-car plans (which could easily attract partnerships) and even the forgotten Covid-19 thingy.